## **Core Concept**
The question tests the understanding of the renin-angiotensin-aldosterone system (RAAS) and its response to different classes of antihypertensive drugs. Renin is an enzyme released by the kidneys that plays a crucial role in regulating blood pressure through the RAAS pathway.

## **Why the Correct Answer is Right**
Prolonged use of **diuretics**, especially those acting on the distal convoluted tubule and collecting duct like thiazides and loop diuretics, leads to increased renin release. This occurs due to decreased blood volume and sodium delivery to the distal tubules, triggering a compensatory response that activates the RAAS. This results in increased renin secretion.

## **Why Each Wrong Option is Incorrect**
* **Option A:** Beta blockers actually decrease renin release. They work by blocking beta-1 adrenergic receptors in the juxtaglomerular cells of the kidneys, which are responsible for renin secretion. Therefore, beta blockers reduce renin levels.
* **Option B:** ACE inhibitors (Angiotensin-Converting Enzyme inhibitors) block the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor that also stimulates aldosterone release. While they do affect the RAAS pathway, their use leads to decreased feedback inhibition on renin release, but the direct effect is not an increase in renin due to negative feedback mechanisms; instead, they allow renin levels to rise because they prevent the formation of angiotensin II, which normally inhibits renin release.
* **Option D:** Calcium channel blockers primarily cause vasodilation and do not have a direct significant effect on the RAAS system that would lead to increased renin levels as a primary mechanism of action.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **diuretics** can lead to secondary hyperaldosteronism due to increased renin release, which can cause hypokalemia. This is a critical consideration in patients on long-term diuretic therapy.

## **Correct Answer:** C. Diuretics